CASR and hypertensive disorder: These interventions not only reduce proteinuria and preserve the GFR but also limit immune infiltration and fibrosis, supporting a pathophysiological role for the CaSR at the intersection of oxidative, immune, and tubular injury in hypertension-induced nephropathy.